Catheter-based aortic valve replacement is on a par with surgical aortic valve replacement, even in younger low-risk patients. This is the result of the one-year evaluation of the DEDICATE-DZHK6 study, which was conducted under the direction of Prof. Dr Stefan Blankenberg at the...

Hier finden Sie eine Auswahl an Programmpunkten, an denen das DZHK beteilgt ist. Außerdem freuen wir uns, Sie wieder am DZHK-Stand (gleich neben der Medienannahme) begrüßen zu dürfen.

Leading mid-career researchers in Germany, the Netherlands and the UK will join forces to drive breakthroughs in the detection, diagnosis and treatment of heart and circulatory diseases, thanks to a pioneering partnership between the British Heart Foundation (BHF), Dutch Heart...

In clinical trials, new therapies or drugs are tested on a large number of patients or healthy volunteers: Nothing works without biometrics. This is because studies have to be statistically planned, systematically checked and carefully analysed. This is Tim Friede's speciality:...

Unique in the world: laboratory-grown heart tissue has been implanted in patients with heart failure as part of a study conducted by the University Medical Center Göttingen (UMG) and the University Hospital Schleswig-Holstein (UKSH). The so-called heart patch is intended to...

There are many drugs that can be used to lower high blood pressure. However, not every active ingredient is suitable for everyone. This diversity makes blood pressure control an art - and an opportunity for those affected. DZHK scientist Prof Dr Thomas Eschenhagen in...

The publication by PD Dr Alessio Alogna from the Deutsches Herzzentrum der Charité Berlin on nano-in-microtechnology from the lungs to the heart was named DZHK Paper of the Month February 2024.

The Goethe University is strengthening its research and teaching on artificial intelligence: DZHK scientist Prof Dr Marcel H. Schulz, previously Junior Professor of Computational Biology at the Goethe University, is taking up a professorship for artificial intelligence in genome...

Researchers at Deutsches Herzzentrum der Charité led by study director and DZHK scientist PD Dr Felix Hohendanner, in collaboration with the Mayo Clinic in the USA, are conducting a new study to find out how patients with advanced heart failure can be monitored telemedically via...

Endothelial cells of the smallest vessels are proving to be a promising therapeutic target for organ fibrosis.